A pilot phase II study of peglylated liposomal doxorubicin (Doxil) with rituximab in relapsed AIDS-related non-Hodgkin's lymphomas

Trial Profile

A pilot phase II study of peglylated liposomal doxorubicin (Doxil) with rituximab in relapsed AIDS-related non-Hodgkin's lymphomas

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2014

At a glance

  • Drugs Doxorubicin liposomal (Primary) ; Rituximab (Primary)
  • Indications Burkitt's lymphoma; Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2009 Additional lead trial investigator Anil Tulpule identified as reported by ClinicalTrials.gov.
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top